Ryman’s dividend policy is to payout between 30 percent to 50 percent of underlying profit*. Dividends are intended to be paid on a semi-annual basis.
Imputation credits are generally attached to the extent that they are available from taxation payments.
Whenever a dividend is declared we will promptly make an announcement to the market.
Ryman can give no assurance about the level of dividends, the extent of imputation of such dividends, or the payout ratios as these matters depend upon the future profits, Ryman’s tax and financial position at the time and exercise of directors’ discretions.
* Underlying profit is a non-GAAP (Generally Accepted Accounting Principles) measure and differs from NZ IFRS profit for the period. Underlying profit does not have a standardised meaning prescribed by GAAP and so may not be comparable to similar financial information presented by other entities.
Ryman adopted a Dividend Reinvestment Plan in November 2022.
The plan provides shareholders with the opportunity to reinvest all or part of their dividends in additional Ryman Healthcare Limited shares, free of brokerage and other transaction costs, at a 2.5 percent discount to market price at the time entitlements are determined.
The Dividend Reinvestment Plan will be effective for the dividend payable in respect of the six-month period ended 30 September 2022. Participation elections, once given, apply to all future dividends, unless updated. The Board has discretion to suspend or terminate the Plan.
The Dividend Reinvestment Plan Offer Document dated November 2022 is available to download below.